Erratum: Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis

Article metrics

  • A Corrigendum to this article was published on 11 August 2009

Correction to: British Journal of Cancer (2009) 100, 1666–1673, doi: 10.1038/sj.bjc.6605026

Upon publication of this paper in Volume 100, the authors noticed an error in the results section of the Abstract, where HIF-2α was expressed incorrectly as HIF-1α. The correction is now shown below in bold.

RESULTS: MVD was higher across T- and N-stages (P<0.001) and associated with poor survival (Hazard ratio (HR 8.7, P<0.005) and decreased disease-free survival (HR=4.7, P<0.005). HIF-1α and HIF-2α were expressed in >50% of rectal cancers (HIF-1α, 54%, 48/90; HIF-2α, 64%, 58/90). HIF-1α positivity was associated with TNM stage (P<0.05), vascular invasion (P<0.005), recurrence (HR=4.5, P<0.005) and cancer-specific mortality (HR=5.5, P<0.002). In contrast, no associations were demonstrated between HIF-2 α and any pathological features or outcome.

Change history

  • 16 November 2011

    This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication

Additional information

The online version of the original article can be found at 10.1038/sj.bjc.6605242

Rights and permissions

From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/

Reprints and Permissions

About this article

Cite this article

Rasheed, S., Harris, A., Tekkis, P. et al. Erratum: Hypoxia-inducible factor-1α and -2α are expressed in most rectal cancers but only hypoxia-inducible factor-1α is associated with prognosis. Br J Cancer 101, 742 (2009) doi:10.1038/sj.bjc.6605242

Download citation

Further reading